Cerebral infections in AIDS: Mycobacterial and other bacterial infections

Infections in Medicine

Volumn 14, Issue 2, 1997, Pages 162-168

  McArthur, Justin C ^a,c   Harrison, Michael J G ^b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acquired immune deficiency syndrome (AIDS); Clostridia; Listeria; Mycobacterium avium intracellulare complex; Nocardia; Tuberculosis

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BOTULINUM ANTISERUM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; KETOCONAZOLE; MINOCYCLINE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; SULFADIAZINE; TETANUS ANTIBODY; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; BOTULISM; CENTRAL NERVOUS SYSTEM INFECTION; CLOSTRIDIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LISTERIOSIS; LYME DISEASE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NOCARDIOSIS; ORAL DRUG ADMINISTRATION; REVIEW; TETANUS; TOXOPLASMA; TUBERCULOUS MENINGITIS;

EID: 0031470010     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Narain JP, Raviglione MC, Kochi A: HIV-associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tubercle Dis 73:311-321, 1992.
2. Mann JM, Tarantola DJ, Netter TW: AIDS in the World. Cambridge, Mass., Harvard University Press, 1992.
3. Centers for Disease Control and Prevention: Initial therapy for tuberculosis in the era of multi-drug resistance: Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 42:1-8, 1992.
4. Selwin PA, Hartel D, Lewis VA, et al: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency syndrome virus infection. N Engl J Med 320:545-550. 1989.
5. Hopewell PC: Impact of human immunodeficiency virus on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 15:540-547, 1992.
6. PitchenikAE, Fertel D: Tuberculosis and non-tuberculous mycobacterial disease. Med Clin North Am 76:121-171, 1992.
7. Barnes PF, Bloch AB, Davidson PT, et al: Tuberculosis in patients with acquired immunodeficiency virus infection. N Engl J Med 324:1644-1650, 1991.
8. Sudre P, ten Dam G. Kochi A: Tuberculosis: A global overview of the situation today. Bull World Health Organ 70:149-159,1992.
9. Dooley SW, Jarvis WR, Martone WJ, et al: Tuberculosis in patients with acquired immunodeficiency virus infection. Ann Intern Med 117:257-259, 1992.
10. Shafer RW, Kim DS, Weiss JP, et al: Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 70:384-397, 1991.
11. Dube MP, Holtom PD, Larsen RA: Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93:520-524, 1992.
12. Bishburg E, Sunderam G, Reichman L B, et al: Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 105:210-213, 1986.
13. Berenguer J, Moreno S, Laguna F, et al: Tuberculous meningitis in patients with the human immunodeficiency virus. N Engl J Med 326:668-672, 1992.
14. Dismukes WE: Cryptococcal meningitis in patients with AIDS. J Infect Dis 15:624-628, 1988.
15. Doll D, Yarbro J W, Phillips K, Klott C: Mycobacterial spinal cord abscess with an ascending polyneuropathy. Ann Intern Med 106:333-334, 1987.
16. Ruiz A, Ganz WI, Post MJ, et al: Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR 15:1885-1894, 1994.
17. Macapinlac HA, Scott AM, Caluser CI, et al: Utility of Ti-201 SPECT and F-18 FDG PET as an adjunct to CT and MR imaging in the evaluation of metastatic brain tumors. Radiology 185(P):233, 1992. Abstract
18. Kramer F, Modilevsky T, Waliany AR, et al: Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 89:451-456, 1990.
19. Jacobs WR, Barletta RG, Udani R, et al: Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822, 1993.
20. Wilson SM, McNerney R, Nye PM, et al: Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol 31:776-782, 1993.
21. Stoneburner R, Laroche E, Prevots R, et al: Survival in a cohort of human immunodeficiency virus-infected tuberculous patients in New York City. Arch Intern Med 152:2033-2037, 1992.
22. Chawla PK, Klapper PJ, Kamholz SL, et al: Drug resistant tuberculosis in an urban population at risk for human immunodeficiency virus infection. Am Rev Respir Dis 146:280-284, 1992.
23. Monno L, Carbonara S, Costa D, et al: Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet 337:852, 1991.
24. Iseman MD: Treatment of multidrug-resistant tuberculosis. N Engl J Med 329:784-791, 1993.
25. Armstrong D, Gold JWM, Dryjanski J, et al: Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103:738-743, 1985.
26. Benson CA, Ellner JJ: Mycobacterium avium complex infection and AIDS: Advances in theory and practice. Clin Infect Dis 17:7-20, 1993.
27. Nightingale SD, Byrd LT, Southern PM, et al: Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 165:1082-1085, 1992.
28. Benson CA: Mycobacterium tuberculosis and Mycobacterium avium complex disease in patients with HIV infection. Current Opinion in Infectious Diseases 7:95-107, 1994.
29. Zakowski P, Fliegal S, Berlin GW, et al: Disseminated Mycobacterium avium-intracellulare infection in homesexual men dying of acquired immunodeficiency. JAMA 248:2980-2982, 1982.
30. Modilevsky T, Sattler FR, Barnes PF: Mycobacterial disease in patients with human immunodeficiency syndrome virus infection. Arch Intern Med 149:2201-2205, 1989.
31. Byrne E, Brophy BP, Perrett LV: Nocardia cerebral abscess; new concepts in diagnosis, management and prognosis. J Neurol Neurosurg Psychiatry 42:1038-1045, 1979.
32. Levy RM, Bredesen DE: Central nervous system dysfunction in acquired immunodeficiency syndrome, in Rosenblum ML, Levy RM, Bredesen DE (eds):AIDS and the Nervous System. New York: Raven Press, 1988, pp 29-63.
33. Gould IA, Belok LC, Handwerger S: Listeria monocytogenes: A rare cause of opportunistic infection in the acquired immunodeficiency syndrome (AIDS) and a new cause of meningitis in AIDS. Acase report. AIDS Res 2:231-234, 1987.
34. Mascola L, Lieb L, Chiu J, et al: Listeriosis: An uncommon opportunistic infection in patients with acquired immunodeficiency syndrome. Am J Med 84:162-164, 1988.
35. Nakane A, Minagawa T, Kato K: Endogenous tumour necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 56:2563- 2569, 1988.
36. Kennard C, Howard AJ, Scholtz C, et al: Infection of the brain stem by Listeria monocytogenes. J Neurol Neurosurg Psychiatr 42:931-933, 1979.
37. Garcia-Monco JC, Frey HM, Fernandez Villar B, et al: Lyme disease concurrent with human immunodeficiency virus infection. Am J Med 87:325-328, 1989.
38. Williams I, Mindel A, Weller IVD: AIDS Pocket Picture Guide. Philadelphia, Lippincott, 1989, p 84.